1. Home
  2. CYD vs ANIP Comparison

CYD vs ANIP Comparison

Compare CYD & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo China Yuchai International Limited

CYD

China Yuchai International Limited

HOLD

Current Price

$37.32

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$72.75

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYD
ANIP
Founded
1951
2001
Country
Singapore
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
1998
1999

Fundamental Metrics

Financial Performance
Metric
CYD
ANIP
Price
$37.32
$72.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$60.00
$110.00
AVG Volume (30 Days)
204.2K
326.6K
Earning Date
02-24-2026
05-08-2026
Dividend Yield
1.41%
N/A
EPS Growth
N/A
419.23
EPS
N/A
3.32
Revenue
N/A
$206,547,000.00
Revenue This Year
$15.11
$23.05
Revenue Next Year
$8.67
$14.08
P/E Ratio
$32.71
$22.30
Revenue Growth
N/A
2.47
52 Week Low
$12.66
$56.71
52 Week High
$56.55
$99.50

Technical Indicators

Market Signals
Indicator
CYD
ANIP
Relative Strength Index (RSI) 33.90 41.52
Support Level $34.98 $71.29
Resistance Level $41.24 $84.47
Average True Range (ATR) 1.90 2.30
MACD -0.31 0.15
Stochastic Oscillator 9.23 34.97

Price Performance

Historical Comparison
CYD
ANIP

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: